Tamsulosin HCL MR + Dutasteride Tablets

Tamsulosin HCL MR + Dutasteride Tablets are combination medications used for the treatment and long-term management of benign prostatic hyperplasia (BPH). The formulation combines Tamsulosin Hydrochloride Modified Release, an alpha-1 adrenergic receptor blocker that improves urine flow by relaxing smooth muscles in the prostate and bladder neck, with Dutasteride, a 5-alpha reductase inhibitor that reduces prostate enlargement by lowering dihydrotestosterone (DHT) levels. Genliva Wellness LLP is a trusted Tamsulosin HCL MR + Dutasteride Tablet Manufacturer in India offering high-quality urology formulations for domestic and international pharmaceutical markets.

This combination therapy is widely prescribed for men with moderate to severe prostate enlargement and associated urinary symptoms. The modified-release technology of Tamsulosin provides sustained symptom control, while Dutasteride addresses the underlying progression of the disease. As a reliable Tamsulosin HCL MR + Dutasteride Tablet Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Tamsulosin HCL MR + Dutasteride Tablets are recognized as an effective therapeutic option for improving urinary function and reducing the risk of BPH progression. Genliva Wellness LLP also provides Tamsulosin HCL MR + Dutasteride Tablet Contract Manufacturing in India and third-party manufacturing services for pharmaceutical companies globally.